Cargando…

Standardized Uptake Values on SPECT/CT: A Promising Alternative Tool for Treatment Evaluation and Prognosis of Metastatic Neuroendocrine Tumours

(1) Background: The aim of our study was to assess the feasibility of (99m)TcEDDA/HYNIC-TOC SPECT/CT quantitative analysis in evaluating treatment response and disease progression in patients with NETs. (2) Methods: This prospective monocentric study evaluated 35 SPECT/CT examinations performed on 1...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gherghe, Mirela, Lazar, Alexandra Maria, Simion, Laurentiu, Irimescu, Ionela-Nicoleta, Sterea, Maria-Carla, Mutuleanu, Mario-Demian, Anghel, Rodica Maricela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857822/ https://www.ncbi.nlm.nih.gov/pubmed/36673128 http://dx.doi.org/10.3390/diagnostics13020318

Ejemplares similares

Quantitative Analysis of SPECT-CT Data in Metastatic Breast Cancer Patients—The Clinical Significance
por: Gherghe, Mirela, et al.
Publicado: (2022)

Quantitative Assessment of Treatment Response in Metastatic Breast Cancer Patients by SPECT-CT Bone Imaging—Getting Closer to PET-CT
por: Gherghe, Mirela, et al.
Publicado: (2023)

Quantitative vs. Qualitative SPECT-CT Diagnostic Accuracy in Bone Lesion Evaluation—A Review of the Literature
por: Mutuleanu, Mario-Demian, et al.
Publicado: (2023)

Quantitative SPECT/CT Parameters in the Assessment of Transthyretin Cardiac Amyloidosis—A New Dimension of Molecular Imaging
por: Gherghe, Mirela, et al.
Publicado: (2023)

The New Radiolabeled Peptide (99m)TcEDDA/HYNIC-TOC: Is It a Feasible Choice for Diagnosing Gastroenteropancreatic NETs?
por: Gherghe, Mirela, et al.
Publicado: (2022)

Radiomics Analysis of [(18)F]FDG PET/CT Thyroid Incidentalomas: How Can It Improve Patients’ Clinical Management? A Systematic Review from the Literature
por: Gherghe, Mirela, et al.
Publicado: (2022)

Feasibility of Sentinel Lymph Node Biopsy in Breast Cancer Patients with Axillary Conversion after Neoadjuvant Chemotherapy—A Single-Tertiary Centre Experience and Review of the Literature
por: Lazar, Alexandra Maria, et al.
Publicado: (2023)

Evaluating Cardiotoxicity in Breast Cancer Patients Treated with HER2 Inhibitors: Could a Combination of Radionuclide Ventriculography and Cardiac Biomarkers Predict the Cardiac Impact?
por: Gherghe, Mirela, et al.
Publicado: (2022)

Long-Term Outcome of Patients with Stage II and III Muscle-Invasive Urothelial Bladder Cancer after Multimodality Approach. Which Is the Best Option?
por: Trifanescu, Oana Gabriela, et al.
Publicado: (2022)

Therapies beyond Physiological Barriers and Drug Resistance: A Pilot Study and Review of the Literature Investigating If Intrathecal Trastuzumab and New Treatment Options Can Improve Oncologic Outcomes in Leptomeningeal Metastases from HER2-Positive Breast Cancer
por: Trifănescu, Oana Gabriela, et al.
Publicado: (2023)

Understanding COVID Vaccination and Its Implication in Cancer Patients’ Imaging of Lymph Nodes by PET-CT
por: Gales, Laurentia Nicoleta, et al.
Publicado: (2022)

Iodine-131MIBG SPECT/CT in neuroendocrine tumours: An institutional experience
por: Verma, Priyanka, et al.
Publicado: (2012)

Analysis of Efficacy-To-Safety Ratio of Angiogenesis-Inhibitors Based Therapies in Ovarian Cancer: A Systematic Review and Meta-Analysis
por: Simion, Laurentiu, et al.
Publicado: (2023)

Validation of a New Prognostic Score in Patients with Ovarian Adenocarcinoma
por: Trifanescu, Oana Gabriela, et al.
Publicado: (2023)

The Female Reproductive Tract Microbiome and Cancerogenesis: A Review Story of Bacteria, Hormones, and Disease
por: Trifanescu, Oana Gabriela, et al.
Publicado: (2023)

Assessment of Immune Status in Dynamics for Patients with Cancer Undergoing Immunotherapy
por: Xenia Elena, Bacinschi, et al.
Publicado: (2021)

Can DCE-MRI Explain the Heterogeneity in Radiopeptide Uptake Imaged by SPECT in a Pancreatic Neuroendocrine Tumor Model?
por: Bol, Karin, et al.
Publicado: (2013)

Improved Benefit of SPECT/CT Compared to SPECT Alone for the Accurate Localization of Endocrine and Neuroendocrine Tumors
por: Bural, Gonca G., et al.
Publicado: (2012)

Uptake of meta-iodobenzylguanidine in neuroendocrine tumours is mediated by vesicular monoamine transporters
por: Kölby, L, et al.
Publicado: (2003)

Long-term oncological outcome in patients with cervical cancer after 3 trimodality treatment (radiotherapy, platinum-based chemotherapy, and robotic surgery)
por: Trifanescu, Oana Gabriela, et al.
Publicado: (2021)

The Diagnostic Efficiency of 99mTc-EDDA/HYNIC-Octreotate SPECT-CT in Comparison with 111In-Pentetrotide in the Detection of Neuroendocrine Tumours
por: Koçyiğit Deveci, Emel, et al.
Publicado: (2013)

Eosinophilic, polymorphic, and pruritic eruption associated with radiation therapy in two patients diagnosed with prostate cancer
por: Barbu, Maria Alexandra, et al.
Publicado: (2023)

Immuno-imaging of ICAM-1 in tumours by SPECT
por: Mosley, Michael, et al.
Publicado: (2020)

Preclinical Evaluation of [(155/161)Tb]Tb-Crown-TATE—A Novel SPECT Imaging Theranostic Agent Targeting Neuroendocrine Tumours
por: Wharton, Luke, et al.
Publicado: (2023)

Potential clinically useful prognostic biomarkers in triple-negative breast cancer: preliminary results of a retrospective analysis
por: Ilie, Silvia Mihaela, et al.
Publicado: (2018)

Noninvasive intravital high-resolution imaging of pancreatic neuroendocrine tumours
por: Balan, Mirela, et al.
Publicado: (2019)

Salvage Surgery for Small-Cell Lung Cancer—A Literature Review
por: Motas, Natalia, et al.
Publicado: (2023)

Neuroendocrine tumours and their microenvironment
por: de Hosson, Lotte D., et al.
Publicado: (2020)

CT-based quantitative SPECT for the radionuclide (201)Tl: experimental validation and a standardized uptake value for brain tumour patients
por: Willowson, Kathy, et al.
Publicado: (2012)

The Cytotoxic Effect of Magainin II on the MDA-MB-231 and M14K Tumour Cell Lines
por: Anghel, Radu, et al.
Publicado: (2013)

Tumour-infiltrating cytotoxic T lymphocytes in somatotroph pituitary neuroendocrine tumours
por: Iacovazzo, Donato, et al.
Publicado: (2019)

CT/MRI of neuroendocrine tumours
por: Reznek, Rodney H
Publicado: (2006)

Guidelines for the management of neuroendocrine tumours by the Brazilian gastrointestinal tumour group
por: Riechelmann, Rachel P, et al.
Publicado: (2017)

Chemokines modulate the tumour microenvironment in pituitary neuroendocrine tumours
por: Marques, Pedro, et al.
Publicado: (2019)

Brain SPECT scans: A promising research tool for specific learning disability
por: Meng, Z, et al.
Publicado: (2019)

Prognostic Role of Vascular Endothelial Growth Factor and Correlation with Oxidative Stress Markers in Locally Advanced and Metastatic Ovarian Cancer Patients
por: Trifanescu, Oana Gabriela, et al.
Publicado: (2023)

Circulating tumour cells and tumour biomarkers in functional midgut neuroendocrine tumours
por: Meyer, Tim, et al.
Publicado: (2022)

(90)Y SPECT/CT quantitative study and comparison of uptake with pretreatment (99 m)Tc‐MAA SPECT/CT in radiomicrosphere therapy
por: Debebe, Senait Aknaw, et al.
Publicado: (2019)

Comparison of the mutational profiles of neuroendocrine breast tumours, invasive ductal carcinomas and pancreatic neuroendocrine carcinomas
por: Karihtala, Peeter, et al.
Publicado: (2022)

Aspects Regarding the Influence of Obesity on the Molecular Characteristics of Breast Tumors
por: Pantelimon, Iuliana, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kinrnthcf9pb37hq16qeg47t9b